According to the ruling of the Munich District Court, Generic drug company Stada, Zentiva and Hikma Generic products containing the active ingredient pemetrexed cannot continue to be marketed on the German market.

        For years, Lilly has always been the No EP1313508 Patent infringement and validity issues with major generic drug manufacturers. The patent protects pemetrexed disodium salts and vitamins B12 Combined use of. Lilly's drugs take Alimta Selling for the brand name, Palliative chemotherapy for certain advanced lung cancers.

        7 Early month, Germany's Federal Supreme Court ruled No EP1313508 Valid patent No, Overruled the federal patent Court 2018 years 7 Verdict of the month, So it turns around 2018 Generic drug companies rushed to launch their products in Germany after the invalidation ruling in 2005.

        In addition, in 8 After the next update in mid-month, German Institute of Occupational Health and Safety for Statutory Accident Insurance, Munich (IFA) Will no longer list generic drug information in its database. IFA Is an information service provider for the German pharmaceutical market, It maintains an online database containing information on medical products and medicines in Germany. but, IFA Products not listed in the database cannot be sold through pharmacies.

        Reprinted from China Intellectual Property Network

        disclaimer: This website reprint articles are from the Internet, Does not represent the views of this website or confirm the authenticity of its content. If the source is mislabeled or the copyright of the article is involved, Please contact this website, This website will be corrected in due course, delete, thank you.